Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine

CNS Drugs. 2018 Jun;32(6):559-565. doi: 10.1007/s40263-018-0532-6.

Leda Marina Pomes¹, Giovanna Gentile^{2

3}, Maurizio Simmaco^{2

3}, Marina Borro^{2

3}, Paolo Martelletti^{4

5

6}

¹ Residency Program in Laboratory Medicine, Gabriele d'Annunzio University, Chieti, Italy.
² Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Rome, Italy.
³ Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
⁴ Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy. paolo.martelletti@uniroma1.it.
⁵ Internal Medicine and Emergency Medicine Unit, Sant'Andrea Hospital, Rome, Italy. paolo.martelletti@uniroma1.it.
⁶ Regional Referral Headache Center, Sant'Andrea Hospital, Rome, Italy. paolo.martelletti@uniroma1.it.

No abstract available

Publication types